[Form 4] HANCOCK WHITNEY CORP Insider Trading Activity
Carleton Richard Wilkins, a director of Hancock Whitney Corp (HWC), reported a non-derivative purchase of common stock on 09/26/2025. The filing shows an acquisition of 31.62 shares at a price of $63.26 per share, bringing the reporting person’s total direct beneficial ownership to 17,818.8023 shares. The report also discloses indirect holdings of 600 shares via a Children’s Trust and 1,177 shares attributed to a spouse. The filing notes the reported shares include shares acquired through the company’s Dividend Reinvestment Plan. The form was signed by a power of attorney on 09/30/2025.
Carleton Richard Wilkins, un direttore di Hancock Whitney Corp (HWC), ha riportato un acquisto non derivato di azioni ordinarie in data 26/09/2025. La comunicazione mostra un'acquisizione di 31,62 azioni al prezzo di $63,26 per azione, portando la quota diretta di proprietà beneficiaria del dichiarante a 17.818,8023 azioni. La relazione segnala anche partecipazioni indirette di 600 azioni tramite un Children’s Trust e 1.177 azioni attribuite al coniuge. La dichiarazione indica che le azioni riportate includono azioni acquisite tramite il Piano di reinvestimento dei dividendi. Il modulo è stato firmato da un procuratore il 30/09/2025.
Carleton Richard Wilkins, director de Hancock Whitney Corp (HWC), informó la compra no derivada de acciones comunes el 26/09/2025. La comunicación muestra una adquisición de 31,62 acciones a un precio de $63,26 por acción, llevando la propiedad benéfica directa del informante a 17.818,8023 acciones. El informe también revela participaciones indirectas de 600 acciones a través de un Children’s Trust y 1.177 acciones atribuidas a un cónyuge. La declaración indica que las acciones reportadas incluyen acciones adquiridas a través del Dividend Reinvestment Plan. El formulario fue firmado por un apoderado el 30/09/2025.
Carleton Richard Wilkins는 Hancock Whitney Corp(HWC)의 이사로서 2025년 9월 26일에 비파생 일반주식 매수를 보고했습니다.
보고서에 따르면 주당 가격 $63.26에 31.62주를 인수하여 피보고자의 직접적 유익 소유 총주식 수를 17,818.8023주로 늘렸습니다. 또한 600주를 Children’s Trust를 통해 간접 보유하고 있으며, 배우자 명의로 1,177주가 기재되어 있습니다. 보고서에는 보고된 주식이 회사의 배당 재투자 계획을 통해 취득된 주식을 포함한다는 내용도 명시되어 있습니다. 이 양식은 2025년 9월 30일에 대리인에 의해 서명되었습니다.
Carleton Richard Wilkins, administrateur de Hancock Whitney Corp (HWC), a déclaré l'achat non dérivé d'actions ordinaires le 26/09/2025. Le dépôt indique l'acquisition de 31,62 actions à un prix de $63,26 par action, portant la propriété bénéficiaire directe du déclarant à 17 818,8023 actions. Le rapport divulgue également des détentions indirectes de 600 actions par le biais d'un Children’s Trust et 1 177 actions attribuées à un conjoint. Le dépôt note que les actions déclarées incluent celles acquises par le biais du Dividend Reinvestment Plan. Le formulaire a été signé par procuration le 30/09/2025.
Carleton Richard Wilkins, ein Direktor der Hancock Whitney Corp (HWC), hat am 26.09.2025 einen nicht derivativen Kauf von Stammaktien gemeldet.
Die Einreichung zeigt den Erwerb von 31,62 Aktien zu einem Preis von $63,26 pro Aktie, wodurch der direkte wirtschaftliche Eigentumsanteil des Meldenden auf 17.818,8023 Aktien steigt. Der Bericht nennt auch indirekte Halte von 600 Aktien über einen Children’s Trust und 1.177 Aktien, die einem Ehepartner zugeordnet sind. Die Einreichung vermerkt, dass die gemeldeten Aktien auch durch den Dividend Reinvestment Plan erworben wurden. Das Formular wurde von einem Bevollmächtigten am 30.09.2025 unterschrieben.
كارلتون ريتشارد ويلكنز، مدير في Hancock Whitney Corp (HWC)، أبلغ عن شراء غير مشتق لأسهم عادية في تاريخ 26/09/2025.
يظهر التقرير شراء 31.62 سهماً بسعر $63.26 للسهم، مما يزيد ملكية المستفيد المباشرة الإجمالية إلى 17,818.8023 سهماً. كما يكشف التقرير عن حيازات غير مباشرة قدرها 600 سهم عبر Children’s Trust و1,177 سهماً نسبت إلى الزوج/الزوجة. يشير التقرير إلى أن الأسهم المذكورة تتضمن الأسهم المكتسبة من خلال Dividend Reinvestment Plan. ووقّع النموذج بواسطة توكيل في 30/09/2025.
Carleton Richard Wilkins,Hancock Whitney Corp(HWC)的董事,已就< b>2025-09-26报告了非衍生普通股购买。
该披露显示以每股$63.26的价格购买了31.62股,使报告人直接受益所有权总数达到17,818.8023股。此外,还通过一个Children’s Trust间接持有600股,以及配偶名下的1,177股。披露还指出,所列股票包含通过公司< b>股息再投资计划获得的股票。该表格由授权代理于2025-09-30签署。
- None.
- None.
Insights
TL;DR: Small insider share purchase via DRIP; disclosure confirms holdings and routine insider activity.
The transaction is a modest non-derivative purchase of 31.62 common shares at $63.26, consistent with dividend reinvestment activity rather than a material open-market purchase. Total direct beneficial ownership is reported as 17,818.8023 shares with additional indirect holdings of 600 and 1,177 shares. As a director-level filing, this is a routine Section 16 disclosure that increases transparency about insider ownership but appears immaterial to company valuation given the size disclosed.
TL;DR: Proper timely disclosure by a director, transaction appears administrative and non-material.
The Form 4 was filed to report acquisition activity and lists the reporting person as a director. The explanatory note clarifies the inclusion of Dividend Reinvestment Plan shares since the last filing, which often results in fractional-share reporting and unusual decimals in total holdings. The signature by POA and the timely date stamps indicate compliance with filing procedures. No derivatives, option exercises, or other compensatory grants are reported.
Carleton Richard Wilkins, un direttore di Hancock Whitney Corp (HWC), ha riportato un acquisto non derivato di azioni ordinarie in data 26/09/2025. La comunicazione mostra un'acquisizione di 31,62 azioni al prezzo di $63,26 per azione, portando la quota diretta di proprietà beneficiaria del dichiarante a 17.818,8023 azioni. La relazione segnala anche partecipazioni indirette di 600 azioni tramite un Children’s Trust e 1.177 azioni attribuite al coniuge. La dichiarazione indica che le azioni riportate includono azioni acquisite tramite il Piano di reinvestimento dei dividendi. Il modulo è stato firmato da un procuratore il 30/09/2025.
Carleton Richard Wilkins, director de Hancock Whitney Corp (HWC), informó la compra no derivada de acciones comunes el 26/09/2025. La comunicación muestra una adquisición de 31,62 acciones a un precio de $63,26 por acción, llevando la propiedad benéfica directa del informante a 17.818,8023 acciones. El informe también revela participaciones indirectas de 600 acciones a través de un Children’s Trust y 1.177 acciones atribuidas a un cónyuge. La declaración indica que las acciones reportadas incluyen acciones adquiridas a través del Dividend Reinvestment Plan. El formulario fue firmado por un apoderado el 30/09/2025.
Carleton Richard Wilkins는 Hancock Whitney Corp(HWC)의 이사로서 2025년 9월 26일에 비파생 일반주식 매수를 보고했습니다.
보고서에 따르면 주당 가격 $63.26에 31.62주를 인수하여 피보고자의 직접적 유익 소유 총주식 수를 17,818.8023주로 늘렸습니다. 또한 600주를 Children’s Trust를 통해 간접 보유하고 있으며, 배우자 명의로 1,177주가 기재되어 있습니다. 보고서에는 보고된 주식이 회사의 배당 재투자 계획을 통해 취득된 주식을 포함한다는 내용도 명시되어 있습니다. 이 양식은 2025년 9월 30일에 대리인에 의해 서명되었습니다.
Carleton Richard Wilkins, administrateur de Hancock Whitney Corp (HWC), a déclaré l'achat non dérivé d'actions ordinaires le 26/09/2025. Le dépôt indique l'acquisition de 31,62 actions à un prix de $63,26 par action, portant la propriété bénéficiaire directe du déclarant à 17 818,8023 actions. Le rapport divulgue également des détentions indirectes de 600 actions par le biais d'un Children’s Trust et 1 177 actions attribuées à un conjoint. Le dépôt note que les actions déclarées incluent celles acquises par le biais du Dividend Reinvestment Plan. Le formulaire a été signé par procuration le 30/09/2025.
Carleton Richard Wilkins, ein Direktor der Hancock Whitney Corp (HWC), hat am 26.09.2025 einen nicht derivativen Kauf von Stammaktien gemeldet.
Die Einreichung zeigt den Erwerb von 31,62 Aktien zu einem Preis von $63,26 pro Aktie, wodurch der direkte wirtschaftliche Eigentumsanteil des Meldenden auf 17.818,8023 Aktien steigt. Der Bericht nennt auch indirekte Halte von 600 Aktien über einen Children’s Trust und 1.177 Aktien, die einem Ehepartner zugeordnet sind. Die Einreichung vermerkt, dass die gemeldeten Aktien auch durch den Dividend Reinvestment Plan erworben wurden. Das Formular wurde von einem Bevollmächtigten am 30.09.2025 unterschrieben.